HEMODYNAMIC ASYMMETRY IN UNILATERAL RENAL ARTERY STENOSIS REVEALED BY COMPUTATIONAL FLUID DYNAMICS ANALYSIS AND iPSC-BASED 3D ARTERY MODELS

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
 
HEMODYNAMIC ASYMMETRY IN UNILATERAL RENAL ARTERY STENOSIS REVEALED BY COMPUTATIONAL FLUID DYNAMICS ANALYSIS AND iPSC-BASED 3D ARTERY MODELS

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Shun
Itai
Shun Itai shun.itai.d8@tohoku.ac.jp Tohoku University Graduate School of Biomedical Engineering Sendai Japan *
Takafumi Toyohara takafumi.toyohara.e6@tohoku.ac.jp Tohoku University Graduate School of Biomedical Engineering Sendai Japan -
Reina Usami usami.reina.s6@dc.tohoku.ac.jp Tohoku University Graduate School of Biomedical Engineering Sendai Japan -
Mayuko Korekata mayuko.korekata.p6@dc.tohoku.ac.jp Tohoku University Graduate School of Biomedical Engineering Sendai Japan -
Tetsuhiro Tanaka tetsuhiro.tanaka.d3@tohoku.ac.jp Tohoku University Graduate School of Biomedical Engineering Sendai Japan -
Takaaki Abe takaaki.abe.d1@tohoku.ac.jp Tohoku University Graduate School of Biomedical Engineering Sendai Japan -
 
 
 
 
 
 
 
 
 

Atherosclerosis still has substantial residual risk despite the development of effective therapies. Hemodynamic forces, particularly aberrant shear stress, are plausible drivers of lesion initiation and progression. However, their causal role has been difficult to dissect due to the lack of appropriate experimental models. We therefore focused on unilateral renal artery stenosis (RAS), a natural “internal control” condition in which atherosclerotic stenosis occurs in one renal artery while the contralateral artery remains unaffected under the same systemic milieu.

 Our objectives were twofold: (i) to identify hemodynamic factors associated with focal RAS using computed tomography (CT) angiography data analyzed by computational fluid dynamics (CFD), and (ii) to build a disease-specific, in-vitro vascular model for mechanistic testing (Fig. 1). CT angiograms underwent CFD analysis to quantify microfluidic fields. Guided by these results, bifurcating iPSC vascular models were fabricated to recapitulate stenosis-promoting hemodynamic environments.

CFD analyses were conducted using CT angiography data from 31 analyzable cases of atherosclerotic unilateral RAS, accrued at Tohoku University Hospital over the past 15 years. The aorta and renal arteries were extracted and virtually reconstructed to a healthy baseline using computer-aided design (CAD) software (Solidworks). Patient-specific flow fields were then simulated from the reconstructed 3D geometries in CFD software (COMSOL), with Doppler ultrasound–derived blood pressure and velocity serving as boundary conditions. Additional appropriate boundary conditions were applied to ensure numerical stability.

For in-vitro modeling, representative CT-derived geometries that captured salient hemodynamic features were rebuilt in CAD and used to fabricate disease-specific bifurcating vascular constructs via bioprinting of hydrogel. The human iPSC-derived endothelial cells (ECs) were cultured on the hydrogel lumen to form bifurcation artery models. To assess leukocyte–endothelium interaction, mCherry-expressing iPSC-derived monocytes were perfused through the channels, and adhesion to the EC layer was quantified.

We identified characteristic hemodynamic features associated with the stenosis side, including internal pressure (p < 0.01), maximum flow velocity (p < 0.001), wall shear velocity (p < 0.05), and vorticity (p < 0.05) (Fig.2 (a,b)). In stratified analyses, patients with dyslipidemia show more pronounced characteristics. The results may indicate that differences in flow dynamics influence the interaction of blood molecules with ECs.

By culturing iPSC–derived ECs on bio-printed hydrogel models based on CT analysis, we successfully constructed a bifurcation vascular model that preserved disease-specific shape (Fig. 2 (c)). ECs formed confluent luminal monolayers, and monocytes were perfused under defined flow. Monocyte adhesion was greater on the stenosis-mimicking branch than on the contralateral (healthy-mimicking) branch, consistent with an early atherogenic phenotype (Fig. 2 (d)).

CFD analysis revealed hemodynamic drivers of unilateral RAS, and our system successfully recapitulated key pathophysiological features. This integrated approach enables mechanistic dissection of stenosis under patient-specific flow conditions and provides a novel platform for hypothesis testing and therapy/device development.

Kewords